4 stories mentioning SGX:ULG
Every FINWIRES story that references SGX:ULG, newest first.
UltraGreen.ai (SGX:ULG) received a no-objection notification from the Singapore Exchange Securities Trading for the trading of its shares on the dual currency trading platform of the bourse, according to a Friday stock exchange filing.Effective May 18, the pharmaceutical imaging and fluorescence-guided surgery company will commence trading of its shares in Singapore dollars, in addition to the US dollar.
Singapore shares incurred losses on Tuesday, mirroring regional losses as investors responded negatively to the possibility of the US and Iran returning to hostilities amid a fragile ceasefire.The Straits Times Index (STI), a key benchmark for the Singapore Exchange, ranged between 4,891.83 and 4,920.61 throughout the day. It ended the session at 4,920.61, down 3.70 points or 0.1% compared to Monday's close.In economic news, Singapore's total retail sales rose 4.8% year on year in March, following the 8.3% growth in the preceding month, according to data released by the Department of Statistics Singapore.On the corporate front, shares of UltraGreen.ai (SGX:ULG) dropped over 7% at the close as its total vial shipment fell 8.7% during the first quarter of the year to 280,900 vials from 307,600 vials a year earlier.Overseas-Chinese Banking Corp. or OCBC (SGX:O39) were hardly moved at the close, as it agreed to acquire the retail and wealth management business of HSBC's (HKG:0005) Indonesian arm.Meanwhile, shares of United Overseas Insurance (SGX:U13) were down under 1% as its insurance revenue dropped to SG$24.9 million in the first quarter of the year from SG$27.3 million a year earlier.
UltraGreen.ai (SGX:ULG) was granted regulatory approval in Singapore for Verdye, an indocyanine green injection, according to a Tuesday filing with the Singapore Exchange.The approval allows the company to ramp up its commercialization efforts and expand its partnerships with local healthcare institutions as part of the adoption of its fluorescence-guided technology.The technology is used across multiple surgical procedures.Shares of the healthcare intelligence company were down over 5% in Tuesday's late-morning trade.
UltraGreen.ai's (SGX:ULG) total vial shipment fell 8.7% during the first quarter of the year to 280,900 vials from 307,600 vials a year earlier, according to a Tuesday filing with the Singapore Exchange.During the period, the healthcare intelligence company expanded its regulatory coverage to 41 countries.Shares of the company were down over 5% in Tuesday trading.